Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group - Johnson, KP; Brooks, BR; Cohen, JA; Ford, CC; Goldstein, J; Lisak, RP (Neurology, 1995)